Crisis Center "Dream", Ukraine
* Corresponding author

Article Main Content

Depression is one of the biggest health problems. If patient has symptoms of depression, then the patient should be treated. Patients with depression have a four times higher risk of suicide than the general population, which worsens their physical health and overall quality of life. This is associated with an increased risk of coronary heart disease, stroke, pain, alcohol abuse, smoking and illicit drug use. This determines the urgency of the problem of depression at the stage of primary care. A good family-patient relationship is essential in the treatment of depressed patients. In the practice of a general practitioner the prevalence of depression is 5%. Each year, two patients are hospitalized for depression, and one patient commits suicide every other day. The formation of the patient's attitude to the disorder depends on the correct assessment by doctor. There is a need for a clear ability to use various depression screening tools be general practitioners. This article discusses some available recommendations for depression management for primary health care physicians.

References

  1. Lebedyn, Z. (2020). Antidepressants In General Practice And Psychiatry. European Journal of Medical and Health Sciences, 2(3). https://doi.org/10.24018/ejmed.2020.2.3.318.
     Google Scholar
  2. Petlovanyi, P., & Tsarkov, A. (2017). Depressive Disorder in Child Psychiatric Practice: A Case Report. Health Press Zambia Bull, 1(5), 9.
     Google Scholar
  3. Tsarkov, A., & Petlovanyi, P. Depressive Disorder in Child Psychiatric Practice: A. The Health Press, 9.
     Google Scholar
  4. Siu, A. L., Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., & Krist, A. H. (2016). Screening for depression in adults: US Preventive Services Task Force recommendation statement. Jama, 315(4), 380-387.
    DOI  |   Google Scholar
  5. Anatolii, T., Patrick, M., & Petro, P. (2020). Uncommon presentation: Folie à deux (Case study). World Journal of Advanced Research and Reviews, 6(3), 043-049.
    DOI  |   Google Scholar
  6. Ben-Porath, Y. S., Butcher, J. N., & Graham, J. R. (1991). Contribution of the MMPI-2 content scales to the differential diagnosis of schizophrenia and major depression. Psychological Assessment: A Journal of Consulting and Clinical Psychology, 3(4), 634.
    DOI  |   Google Scholar
  7. Tsarkov, A., & Petlovanyi, P. (2016). Bipolar Disorder in Child Psychiatric Practice: A Case Report. Medical Journal of Zambia, 43(1), 41-46.
     Google Scholar
  8. Tsarkov, A., & Petlovanyi, P. (2016). Bipolar disorder in child psychiatric practice.
     Google Scholar
  9. Katz, S. J., Kessler, R. C., Lin, E., & Wells, K. B. (1998). Medication management of depression in the United States and Ontario. Journal of General Internal Medicine, 13(2), 77-85.
    DOI  |   Google Scholar
  10. Petlovanyi, P., & Tsarkov, A. Child Schizophrenia: Theory and Practice.
     Google Scholar
  11. Tsarkov, A., & Petlovanyi, P. (2019). Neuropsychiatric Aspects of a Common Problem: Stroke. European Journal of Medical and Health Sciences, 1(3). https://doi.org/10.24018/ejmed.2019.1.3.64.
    DOI  |   Google Scholar
  12. Petlovanyi, P., & Tsarkov, A. (2020). Child Schizophrenia: Theory and Practice. European Journal of Medical and Health Sciences, 2(1). https://doi.org/10.24018/ejmed.2020.2.1.160.
    DOI  |   Google Scholar
  13. Janssen, N., Huibers, M. J., Lucassen, P., Voshaar, R. O., van Marwijk, H., Bosmans, J., ... & Hendriks, G. J. (2017). Behavioural activation by mental health nurses for late-life depression in primary care: a randomized controlled trial. BMC psychiatry, 17(1), 1-11.
    DOI  |   Google Scholar
  14. Parker, G., & Fletcher, K. (2007). Treating depression with the evidence‐based psychotherapies: a critique of the evidence. Acta Psychiatrica Scandinavica, 115(5), 352-359.
    DOI  |   Google Scholar
  15. Pagnin, D., de Queiroz, V., Pini, S., & Cassano, G. B. (2004). Efficacy of ECT in depression: a meta-analytic review. The journal of ECT, 20(1), 13-20.
    DOI  |   Google Scholar
  16. Tsarkov, A., & Petlovanyi, P. (2017). Omega-3 Fatty Acids as an Alternative Treatment for Children with Attention Deficit Hyperactivity Disorder. Imperial Journal of Interdisciplinary Research (IJIR), 3, 1378-1380.
     Google Scholar
  17. Tsarkov, A., & Petlovanyi, P. The Role of Lamotrigine in the Treatment of Bipolar Depression.
     Google Scholar
  18. O’Neil, A., Berk, M., Venugopal, K., Kim, S. W., Williams, L. J., & Jacka, F. N. (2014). The association between poor dental health and depression: findings from a large-scale, population-based study (the NHANES study). General hospital psychiatry, 36(3), 266-270.
    DOI  |   Google Scholar
  19. Phiri, C., Tsarkov, A., Petlovanyi, P., & Lingenda, G. Factors Contributing To Oral Diseases and Treatment Needs amongst Mental Patients at Chainama Hills College Hospital, Lusaka, Zambia.
     Google Scholar
  20. Lebedyn, Z. (2019). The Use of Antidepressants by General Practitioners and Psychiatrists (Personal Experience).
    DOI  |   Google Scholar
  21. Tsarkov, A., & Petlovanyi, P. (2017). Pathological Gambling: The Old Problem of the Modern World. Imperial Journal of Interdisciplinary Research, 3(8), 216-221.
     Google Scholar
  22. Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., & McInerney, S. J. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. The Canadian Journal of Psychiatry, 61(9), 540-560.
    DOI  |   Google Scholar